Chemotherapy Induced Nausea and Vomiting

Taking control of CINV: 

update and perspectives on antiemetic usage and strategies

On demand webcast based on the MASCC/ISOO 2018 Annual Meeting 

Webcast

Please take a moment to complete the pre-activity questions.

Pre-activity questions

Getting a grip on the guidelines: understanding antiemetic usage and barriers to adherence

Florian Scotté, MD, PhD – Chair | Hôpital Foch, Suresnes, France

Achieving control of CINV with NK1 receptor antagonists: making the most of available medications

Snežana Bošnjak, MD, PhD | Institute for Oncology and Radiology of Serbia, Belgrade, Serbia

Optimizing CINV management: applying evidence in clinical practice

Petra Tesařová | Charles University Hospital Prague, Czech Republic

Chair Summary

Florian Scotté, MD, PhD – Chair | Hôpital Foch, Suresnes, France

Please take a moment to complete the post-activity questions

Post-activity questions

Course description

What are the most effective ways to achieve control of chemotherapy-induced nausea and vomiting (CINV)? In this webcast, leading experts discuss practical steps that can be taken to improve control in patients with CINV, including adherence to current antiemetic guidelines and the appropriate use of NK1 receptor antagonists and fixed-combination regimens.

Target audience

This activity is designed to meet the educational needs of oncologists and nurse practitioners responsible for the management of chemotherapy-induced nausea and vomiting.

Educational objectives

•  Recognize the importance of adherence to antiemetic guidelines in improving CINV control

•  Review the proper use of NK1 receptor antagonists in common cancer settings

•  Summarize and compare the data supporting the use of NK1 receptor antagonists and fixed-combination regimens in antiemetic control

•  Discuss strategies to optimally manage patients receiving NK1 receptor antagonists and fixed-combination regimens to improve guidelines adherence and achieve CINV control

Faculty

Florian Scotté, MD, PhD – Chair
Snežana Bošnjak, MD, PhD
Petra Tesařová, MD, PhD

 

Disclosure of conflicts of interest

It is the policy of Wolters Kluwer and Ology Medical Education that all faculty, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this activity:

 

Non-faculty

Caitlin Coles; Alan Moore; Avia Potashnik; Joke Artmanni; Megan Cannon, PhD; Marijke Verhaaf; hereby state that neither they nor their spouse/life partner have had any financial relationships to products or devices with any commercials interest related to the content of this activity of any amount during the past 12 months.

Financial support

Made possible by a contribution from Helsinn Healthcare SA and Angelini Pharma. Helsinn and Angelini Pharma do not have any influence on the content and all items are subject to independent peer and editorial review.

Provider information

Jointly provided by Wolters Kluwer and Ology Medical Education.

Loading